Back to Journals » Journal of Asthma and Allergy » Volume 9

SJR OA
CiteScore
Impact Factor

Journal of Asthma and Allergy

ISSN: 1178-6965


       

Archive: Volume 9, 2016

Original Research

Technical and clinical validation of an environmental exposure unit for ragweed

Gomes PJ, Lane KJ, Angjeli E, Stein L, Abelson MB

Journal of Asthma and Allergy 2016, 9:215-221

Published Date: 14 December 2016

Review

Aquagenic urticaria: diagnostic and management challenges

Rothbaum R, McGee JS

Journal of Asthma and Allergy 2016, 9:209-213

Published Date: 29 November 2016

Corrigendum

Diagnosis of exercise-induced anaphylaxis: current insights [Corrigendum]

Pravettoni V, Incorvaia C

Journal of Asthma and Allergy 2016, 9:207-208

Published Date: 22 November 2016

Review

Chronic sphenoid rhinosinusitis: management challenge

Charakorn N, Snidvongs K

Journal of Asthma and Allergy 2016, 9:199-205

Published Date: 9 November 2016

Review

Diagnosis of exercise-induced anaphylaxis: current insights

Pravettoni V, Incorvaia C

Journal of Asthma and Allergy 2016, 9:191-198

Published Date: 27 October 2016

Original Research

Anti-inflammatory dosing of theophylline in the treatment of status asthmaticus in children

Eid NS, O'Hagan A, Bickel S, Morton R, Jacobson S, Myers JA

Journal of Asthma and Allergy 2016, 9:183-189

Published Date: 13 October 2016

Review

Chronic hypersensitivity pneumonitis

Pereira CA, Gimenez A, Kuranishi L, Storrer K

Journal of Asthma and Allergy 2016, 9:171-181

Published Date: 21 September 2016

Original Research

Study of the correlations between fractional exhaled nitric oxide in exhaled breath and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children

Nguyen-Thi-Bich H, Duong-Thi-Ly H, Thom VT, Pham-Thi-Hong N, Dinh LD, Le-Thi-Minh H, Craig TJ, Duong-Quy S

Journal of Asthma and Allergy 2016, 9:163-170

Published Date: 14 September 2016

Review

Reslizumab in the management of poorly controlled asthma: the data so far

Maselli DJ, Velez MI, Rogers L

Journal of Asthma and Allergy 2016, 9:155-162

Published Date: 31 August 2016

Original Research

Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease

Price DB, Rigazio A, Buatti Small M, Ferro TJ

Journal of Asthma and Allergy 2016, 9:145-154

Published Date: 26 August 2016

Review

A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US

Prenner BM

Journal of Asthma and Allergy 2016, 9:135-143

Published Date: 11 July 2016

Original Research

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy

Moral A, Moreno V, Girón F, El-Qutob D, Moure JD, Alcántara M, Padial A, Oehling AG, Millán C, de la Torre F

Journal of Asthma and Allergy 2016, 9:129-133

Published Date: 29 June 2016

Review

Smoking cessation strategies for patients with asthma: improving patient outcomes

Perret JL, Bonevski B, McDonald CF, Abramson MJ

Journal of Asthma and Allergy 2016, 9:117-128

Published Date: 24 June 2016

Original Research

Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools® pilot survey

Hogue SL, Goss D, Hollis K, Silvia S, White MV

Journal of Asthma and Allergy 2016, 9:109-115

Published Date: 17 June 2016

Review

Update on the role of alternatively activated macrophages in asthma

Jiang ZL, Zhu L

Journal of Asthma and Allergy 2016, 9:101-107

Published Date: 3 June 2016

Review

United airway disease: current perspectives

Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC

Journal of Asthma and Allergy 2016, 9:93-100

Published Date: 11 May 2016

Review

Sleep-disordered breathing in children with asthma: a systematic review on the impact of treatment

Sánchez T, Castro-Rodríguez JA, Brockmann PE

Journal of Asthma and Allergy 2016, 9:83-91

Published Date: 18 April 2016

Review

Benralizumab: a unique IL-5 inhibitor for severe asthma

Tan LD, Bratt JM, Godor D, Louie S, Kenyon NJ

Journal of Asthma and Allergy 2016, 9:71-81

Published Date: 4 April 2016

Original Research

Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy

Horiuchi K, Kasahara K, Kuroda Y, Morohoshi H, Hagiwara Y, Ishii G

Journal of Asthma and Allergy 2016, 9:65-70

Published Date: 18 March 2016

Review

Challenges in the management of severe allergic asthma in the elderly

Ozturk AB, Iliaz S

Journal of Asthma and Allergy 2016, 9:55-63

Published Date: 17 March 2016

Review

Nasal polyps in patients with asthma: prevalence, impact, and management challenges

Langdon C, Mullol J

Journal of Asthma and Allergy 2016, 9:45-53

Published Date: 14 March 2016

Review

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances

Steinke JW, Wilson JM

Journal of Asthma and Allergy 2016, 9:37-43

Published Date: 10 March 2016

Expert Opinion

The asthma–COPD overlap syndrome: how is it defined and what are its clinical implications?

van den Berge M, Aalbers R

Journal of Asthma and Allergy 2016, 9:27-35

Published Date: 10 February 2016

Review

Wheat allergy: diagnosis and management

Cianferoni A

Journal of Asthma and Allergy 2016, 9:13-25

Published Date: 29 January 2016

Original Research

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C

Journal of Asthma and Allergy 2016, 9:1-12

Published Date: 7 January 2016